In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
http://community.amstat.org/BioP/Home/
Gesamtlänge aller Episoden: 3 days 2 hours 4 minutes
Episode 97 - Devan Mehrotra
Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials.
Episode 96: Alan Hartford
Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year.
Episode 95: Anna Nevius
Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009.
Episode 94: Bob Starbuck
Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994.
Episode 93: External Control Arms
Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials.
Episode 92: 2021 Regulatory-Industry Statistics Workshop
Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop.
Episode 91: Patient Reported Outcomes
Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change.
Episode 90: ICSA Leadership Panel
Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace.
Episode 89: Karl Peace
Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium.
Episode 88: Katherine Monti
Katherine Monti was chair of the Biopharmaceutical Section in 2010. She discusses her career in the industry and how the Section has changed over time.